Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis. Criteria and procedures

Overview

Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards.

They provide a set of recommendations that would guide national programme managers in collaboration with their respective oversight committees on when to stop mass drug administration (MDA) and conduct post-treatment surveillance (PTS) activities for a minimum period of 3 to 5 year before confirming the interruption of transmission of Onchocerca volvulus parasite and hence its elimination.

They also include steps to undertake for verification of elimination of transmission of the parasite in the whole endemic country by the International Verification Team (IVT) prior to the official acknowledgement by WHO Director General. 

• Annexes 1 to 7

ASSOCIATED DOCUMENT

• Lignes directrices pour l’arrêt de l’administration de masse de médicaments et la vérification de l’élimination de l’onchocercose humaine : critères et procédures